Sarepta Therapeutics Q1 2026 Earnings Robust EPS Beat Amid Modest Market Caution PCSA Q4 2025 Earnings EPS Misses Estimates Amid Pipeline Development HEI Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Aerospace Demand RPAY Q1 2026 Earnings EPS Beat Drives Positive Market Reaction SLDE Q1 2026 Earnings EPS Surges Past Estimates with 174 Beat RDW Q1 2026 Earnings EPS Misses Estimates Sharply Yet Stock Surges on Strategic Developments